Vascular Surgery Research Group, Imperial College, London, UK.
Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Eur J Vasc Endovasc Surg. 2018 May;55(5):625-632. doi: 10.1016/j.ejvs.2018.01.028. Epub 2018 Mar 1.
OBJECTIVE/BACKGROUND: The aim was to describe the re-interventions after endovascular and open repair of rupture, and investigate whether these were associated with aortic morphology.
In total, 502 patients from the IMPROVE randomised trial (ISRCTN48334791) with repair of rupture were followed-up for re-interventions for at least 3 years. Pre-operative aortic morphology was assessed in a core laboratory. Re-interventions were described by time (0-90 days, 3 months-3 years) as arterial or laparotomy related, respectively, and ranked for severity by surgeons and patients separately. Rare re-interventions to 1 year, were summarised across three ruptured abdominal aortic aneurysm trials (IMPROVE, AJAX, and ECAR) and odds ratios (OR) describing differences were pooled via meta-analysis.
Re-interventions were most common in the first 90 days. Overall rates were 186 and 226 per 100 person years for the endovascular strategy and open repair groups, respectively (p = .20) but between 3 months and 3 years (mid-term) the rates had slowed to 9.5 and 6.0 re-interventions per 100 person years, respectively (p = .090) and about one third of these were for a life threatening condition. In this latter, mid-term period, 42 of 313 remaining patients (13%) required at least one re-intervention, most commonly for endoleak or other endograft complication after treatment by endovascular aneurysm repair (EVAR) (21 of 38 re-interventions), whereas distal aneurysms were the commonest reason (four of 23) for re-interventions after treatment by open repair. Arterial re-interventions within 3 years were associated with increasing common iliac artery diameter (OR 1.48, 95% confidence interval [CI] 0.13-0.93; p = .004). Amputation, rare but ranked as the worst re-intervention by patients, was less common in the first year after treatment with EVAR (OR 0.2, 95% CI 0.05-0.88) from meta-analysis of three trials.
The rate of mid-term re-interventions after rupture is high, more than double that after elective EVAR and open repair, suggesting the need for bespoke surveillance protocols. Amputations are much less common in patients treated by EVAR than in those treated by open repair.
目的/背景:本研究旨在描述腹主动脉瘤破裂血管内修复和开放修复后的再次干预,并探讨这些干预是否与主动脉形态有关。
共有 502 例来自 IMPROVE 随机试验(ISRCTN48334791)的破裂患者接受了至少 3 年的随访,以进行再次干预。术前主动脉形态在核心实验室进行评估。根据时间(0-90 天,3 个月-3 年)将再次干预描述为动脉或剖腹相关,并分别由外科医生和患者对严重程度进行分级。在 IMPROVE、AJAX 和 ECAR 三项腹主动脉瘤破裂试验中,将 1 年内罕见的再次干预进行汇总,并通过荟萃分析计算描述差异的比值比(OR)。
再次干预最常见于前 90 天。血管内治疗组和开放修复组的总发生率分别为每 100 人年 186 次和 226 次(p=0.20),但在 3 个月至 3 年(中期),发生率已降至每 100 人年 9.5 次和 6.0 次(p=0.090),其中约三分之一是危及生命的情况。在后一中期,313 名剩余患者中有 42 名(13%)至少需要进行一次再次干预,最常见的是血管内治疗后发生内漏或其他血管内支架植入并发症(38 次再干预中的 21 次),而开放修复后再次干预最常见的原因是远端动脉瘤(23 次中的 4 次)。3 年内的动脉再次干预与髂总动脉直径的增加有关(OR 1.48,95%置信区间[CI] 0.13-0.93;p=0.004)。截肢,虽然罕见但患者将其评为最差的再次干预,在 EVAR 治疗后的第一年中较少见(OR 0.2,95%CI 0.05-0.88),这是来自三项试验的荟萃分析结果。
破裂后中期再次干预的发生率很高,是择期 EVAR 和开放修复后的两倍多,这表明需要制定专门的监测方案。EVAR 治疗的患者发生截肢的情况明显少于开放修复的患者。